Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial - The Lancet Oncology
Targeted Therapy of Ewing's Sarcoma
Sarcoma treatment in the era of molecular medicine | EMBO Molecular Medicine
Overview of current molecularly targeted therapy for Ewing sarcoma.... | Download Scientific Diagram
Ewing Sarcoma Treatment (PDQ®)–Patient Version - National Cancer Institute
New Strategies in Ewing Sarcoma: Lost in Translation? | Clinical Cancer Research
Is immunotherapy in the future of therapeutic management of sarcomas? | Journal of Translational Medicine | Full Text
Emerging trends in immunotherapy for pediatric sarcomas | Journal of Hematology & Oncology | Full Text
Three-year Follow up of GMCSF/bi-shRNAfurin DNA-transfected Autologous Tumor Immunotherapy (Vigil) in Metastatic Advanced Ewing's Sarcoma - ScienceDirect
PDF) Role of immunotherapy in Ewing sarcoma
Frontiers | Immunotherapy of Childhood Sarcomas | Oncology
Advances in immune checkpoint inhibitors for bone sarcoma therapy - ScienceDirect
Role of immunotherapy in Ewing sarcoma | Journal for ImmunoTherapy of Cancer
Immunotherapy Offers New Strategy for Treating Sarcoma | Memorial Sloan Kettering Cancer Center
Pilot Trial of FANG Immunotherapy in Ewing's Sarcoma: Molecular Therapy
Targeting the undruggable: exploiting neomorphic features of fusion oncoproteins in childhood sarcomas for innovative therapies | SpringerLink
Cellular immunotherapy strategies for Ewing sarcoma | Immunotherapy
Ewing Sarcoma and Undifferentiated Small Round Cell Sarcomas of Bone and Soft Tissue Treatment (PDQ®)–Health Professional Version - National Cancer Institute
New Strategies in Sarcoma: Linking Genomic and Immunotherapy Approaches to Molecular Subtype | Clinical Cancer Research
Frontiers | Targeting Tumor-Associated Macrophages in the Pediatric Sarcoma Tumor Microenvironment | Oncology
Phase II trial of VEGFR2 inhibitor apatinib for metastatic sarcoma: focus on efficacy and safety | Experimental & Molecular Medicine
Advances in immune checkpoint inhibitors for bone sarcoma therapy - ScienceDirect
While Enjoying College, Ewing Sarcoma Survivor Looks to Her Past | Dana-Farber Cancer Institute
Sarcomas: Immune biomarker expression and checkpoint inhibitor trials - Cancer Treatment Reviews
